Skip to main content

Pharma News

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • (15th May, 2014); Researchers from Center of Advanced European Studies and the University Department of Growth and Reproduction find out large amount of endocrine-disrupting chemicals interfere with human sperm function and that may have a negative impact on fertilization. The study indicates that the chemicals might evoke changes in swimming behaviour at the wrong time and wrong place, hinder navigation of sperm towards the egg and hamper penetration into the protective egg coat.

  • (15th May, 2014); Researchers have shown that neurons generated from the skin cells of people with schizophrenia behave unfamiliar in early developmental stages. They used new stem cell research technology for same and they believe that this research may provide new ideas to detect and potentially cure the disease early.

  • Wellcome Trust signs agreement on animal research with 72 other organisations

    (14th May, 2014); Today, the Wellcome Trust has signed a concordat on openness on animal research in the UK. There are 72 other organisations across the scientific sector, including universities, charities, commercial companies, research councils, umbrella bodies and learned societies are joining in concordat.

  • Jubilant Biosys and Orion Corporation Announces Unique Collaborative Discovery Program in Pain Management Area

    (Business Wire India; 13th May, 2014); Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, and Orion Corporation (Orion), the largest pharmaceutical company in Finland, today announced a path breaking drug discovery collaboration to discover small molecule inhibitors in neuroscience therapeutic area. The research deal is aimed at developing drug that can benefit large population of people with unmet needs in the pain management area.

  • First time in India Continuing Pharmaceutical Education (CPE) to be held in Dombivli

    (12th May, 2014); InClinition, a Pharmaceutical and clinical research service providing organization situated in Dombivli, Dist. Thane has announced Continuing Pharmaceutical Education (CPE) discussion forum lecture series. This will be seminar cum networking session for industry and academic professionals.

  • New Study Suggests Desmopressin Melt Improves Sleep Patterns and Psychological Functioning of Bedwetting Children

    (Business Wire India; 12th May, 2014); New data has shown that treatment with melt-in-the-mouth desmopressin (MINIRIN® Melt)* improved sleep patterns and psychological functioning (including attention problems and memory) in children with nocturnal enuresis (bedwetting). The negative impact of bedwetting on children’s neuropsychological functioning (e.g. anxiety and social self-esteem problems) was also shown. The data from a study by researchers at the University Hospital Ghent, Belgium was presented at the 25th annual congress of the European Society for Paediatric Urology (ESPU) in Innsbruck, Austria.

  • CSIR-IHBT developed unique enzyme for creating global niche

    (11th May, 2014); CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, has developed unique autoclavable Super Oxide Dismutase (SOD) enzyme, used in cosmetic, food and pharmaceutical industries for end applications, like developing anti-ageing creams, extending shelf life of fruits and vegetables and during cryo-surgery and preservation of organelles, respectively.

  • ACG's Pithampur Factory Awarded Gold Rating by LEED-India; First in Pharma Industry to Receive the Certification

    (PRNewswire; 6th May, 2014); ACG's continued commitment towards sustainability and efforts in building sustainable sites, reducing water and energy consumption, recycling building material and improving indoor environmental quality has now been recognized. Indian Green Building Council (IGBC) LEED®-India has awarded its prestigious Gold rating to ACG's new state-of-the-art capsule manufacturing plant in Pithampur, making it the first factory in Indian pharmaceutical industry to receive this rating.

  • Eczema may reduce risk of skin cancer

    (6th May, 2014);As per new findings by investigators from King’s College London, Eczema caused by defects in the skin could reduce the risk of developing skin cancer. The immune response generated by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.

  • Researchers made Sperm Cells from Skin of infertile men

    (2nd May, 2014); Team of researchers from Montana State University showing that skin cells from infertile man can be used to create, primary germ cells - precursors of sperm. This research is providing ray of hope for future treatment of male infertility.

Subscribe to Pharma News